The increasing prevalence of chronic conditions, particularly cardiovascular diseases and venous thromboembolism, is driving significant expansion in the anticoagulant sector. The Heparin Market was valued at USD 14,291.77 billion in 2024 and is projected to reach USD 22,268.24 billion by 2032, growing at a CAGR of 7.39% during the forecast period of 2025 to...